Ignite Creation Date:
2025-12-26 @ 10:37 AM
Ignite Modification Date:
2026-03-27 @ 1:09 PM
Study NCT ID:
NCT00691028
Status:
COMPLETED
Last Update Posted:
2014-03-04
First Post:
2008-06-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis
Sponsor:
Tanabe Pharma Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TA-650-13
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
General Manager, Clinical Research Department III
Old Organization:
Mitsubishi Tanabe Pharma Corporation